Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1996 1
1999 1
2000 2
2001 1
2003 2
2005 3
2006 2
2007 1
2008 3
2010 2
2011 1
2012 3
2013 1
2015 2
2016 3
2017 5
2018 1
2019 2
2020 5
2021 4
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Idiopathic fibrosing alveolitis, chronic form"
Page 1
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study.
Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ. Duckworth A, et al. Lancet Respir Med. 2021 Mar;9(3):285-294. doi: 10.1016/S2213-2600(20)30364-7. Epub 2020 Nov 13. Lancet Respir Med. 2021. PMID: 33197388
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease accounting for 1% of UK deaths. In the familial form of pulmonary fibrosis, causal genes have been identified in about 30% of cases, and a majority of these causal ge …
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease accounting for 1% of UK deaths. In the familial …
Respiratory muscle training in children and adults with neuromuscular disease.
Silva IS, Pedrosa R, Azevedo IG, Forbes AM, Fregonezi GA, Dourado Junior ME, Lima SR, Ferreira GM. Silva IS, et al. Cochrane Database Syst Rev. 2019 Sep 5;9(9):CD011711. doi: 10.1002/14651858.CD011711.pub2. Cochrane Database Syst Rev. 2019. PMID: 31487757 Free PMC article.
Respiratory muscle training (RMT) might be expected to improve respiratory muscle weakness; however, the effects of RMT are still uncertain. This systematic review will synthesize the available trial evidence on the effectiveness and safety of RMT in people with NMD, to in …
Respiratory muscle training (RMT) might be expected to improve respiratory muscle weakness; however, the effects of RMT are still uncertain. …
Investigational drugs for idiopathic pulmonary fibrosis.
Varone F, Montemurro G, Macagno F, Calvello M, Conte E, Intini E, Iovene B, Leone PM, Mari PV, Richeldi L. Varone F, et al. Expert Opin Investig Drugs. 2017 Sep;26(9):1019-1031. doi: 10.1080/13543784.2017.1364361. Epub 2017 Aug 10. Expert Opin Investig Drugs. 2017. PMID: 28777013 Review.
IPF is a specific form of chronic fibrosing interstitial pneumonia of unknown cause, characterized by progressive worsening in lung function and an unfavorable prognosis. ...Expert opinion: New IPF drugs are being evaluated in the context of phase 1 and 2 …
IPF is a specific form of chronic fibrosing interstitial pneumonia of unknown cause, characterized by progressive worse …
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
Gibson CD, Kugler MC, Deshwal H, Munger JS, Condos R. Gibson CD, et al. Lung. 2020 Aug;198(4):597-608. doi: 10.1007/s00408-020-00370-1. Epub 2020 Jun 26. Lung. 2020. PMID: 32591895 Review.
Progressive fibrosing interstitial lung disease (PF-ILD) has been redefined as a new clinical syndrome that shares similar genetics, pathophysiology, and natural history to idiopathic pulmonary fibrosis (IPF). IPF is the most common form
Progressive fibrosing interstitial lung disease (PF-ILD) has been redefined as a new clinical syndrome that shares similar gen …
Aging and Susceptibility to Pulmonary Disease.
Budde J, Skloot G. Budde J, et al. Compr Physiol. 2022 Jun 29;12(3):3509-3522. doi: 10.1002/cphy.c210026. Compr Physiol. 2022. PMID: 35766832
The breakdown of cellular mechanisms, including stem cell exhaustion, genomic instability, telomere attrition, epigenetic alteration, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, altered intercellular communication, and chang …
The breakdown of cellular mechanisms, including stem cell exhaustion, genomic instability, telomere attrition, epigenetic alteration, loss o …
Role of Microbial Agents in Pulmonary Fibrosis.
Chioma OS, Drake WP. Chioma OS, et al. Yale J Biol Med. 2017 Jun 23;90(2):219-227. eCollection 2017 Jun. Yale J Biol Med. 2017. PMID: 28656009 Free PMC article. Review.
Pulmonary fibrosis is a form of lung disease that develops due to aberrant wound-healing following repeated alveoli injury in genetically susceptible individuals, resulting in chronic inflammation, excess deposition of the extracellular matrix componen
Pulmonary fibrosis is a form of lung disease that develops due to aberrant wound-healing following repeated alveoli inj
Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.
Magnini D, Montemurro G, Iovene B, Tagliaboschi L, Gerardi RE, Lo Greco E, Bruni T, Fabbrizzi A, Lombardi F, Richeldi L. Magnini D, et al. Respiration. 2017;93(6):379-395. doi: 10.1159/000475780. Epub 2017 May 5. Respiration. 2017. PMID: 28472808 Free article. Review.
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown causes. Current diagnostic criteria are based on radiological, clinical, and histopathological features but,
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstit
Collagen VI as a driver and disease biomarker in human fibrosis.
Williams L, Layton T, Yang N, Feldmann M, Nanchahal J. Williams L, et al. FEBS J. 2022 Jul;289(13):3603-3629. doi: 10.1111/febs.16039. Epub 2021 Jun 14. FEBS J. 2022. PMID: 34109754 Free article. Review.
However, expression is elevated in numerous fibrotic conditions, such as idiopathic pulmonary disease (IPF), and chronic liver and kidney diseases. ...The C-terminal globular domain (C5) of collagen VI alpha3 can be proteolytically cleaved to form a bi …
However, expression is elevated in numerous fibrotic conditions, such as idiopathic pulmonary disease (IPF), and chronic
The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy.
Gharaee-Kermani M, Hu B, Phan SH, Gyetko MR. Gharaee-Kermani M, et al. Expert Opin Investig Drugs. 2008 Jun;17(6):905-16. doi: 10.1517/13543784.17.6.905. Expert Opin Investig Drugs. 2008. PMID: 18491991 Review.
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and frequently fatal form of interstitial lung disease for which there are no proven drug therapies. ...OBJECTIVE: To address the role of urokinase in the pathogenesis of …
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and frequently fatal form of in …
Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE. Canestaro WJ, et al. Chest. 2016 Mar;149(3):756-66. doi: 10.1016/j.chest.2015.11.013. Epub 2016 Jan 13. Chest. 2016. PMID: 26836914 Review.
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a form of chronic progressive fibrosing interstitial lung disease of unknown origin. ...Key outcomes of interest for this analysis were pulmonary function as measured by FVC as wel …
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a form of chronic progressive fibrosing interst …
46 results